D.E. Shaw & Co
GOSS icon

D.E. Shaw & Co’s Gossamer Bio GOSS Stock Holding History

D.E. Shaw & Co’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.74M Buy
511,991
+507,123
+10,417% +$11.3M ﹤0.01% 2169
2026
Q1 		$128K Buy
4,868
+2,384
+96% +$300K ﹤0.01% 4263
2025
Q4 		$616K Sell
2,484
-626
-20% -$143K ﹤0.01% 3829
2025
Q3 		$654K Buy
3,110
+2,400
+338% +$423K ﹤0.01% 3715
2025
Q2 		$69.9K Buy
+710
New +$62K ﹤0.01% 4153
2024
Q2 		– Sell
-7,411
Closed -$700K – 4617
2024
Q1 		$700K Buy
7,411
+1,075
+17% +$94.7K ﹤0.01% 3311
2023
Q4 		$463K Buy
6,336
+2,945
+87% +$174K ﹤0.01% 3546
2023
Q3 		$226K Sell
3,391
-1,319
-28% -$122K ﹤0.01% 3725
2023
Q2 		$452K Buy
4,710
+3,008
+177% +$300K ﹤0.01% 3462
2023
Q1 		$172K Sell
1,702
-2,243
-57% -$343K ﹤0.01% 3932
2022
Q4 		$685K Buy
3,945
+373
+10% +$246K ﹤0.01% 3680
2022
Q3 		$3.42M Buy
3,572
+3,100
+657% +$3.08M ﹤0.01% 2485
2022
Q2 		$316K Sell
472
-64
-12% -$39.7K ﹤0.01% 4333
2022
Q1 		$372K Buy
+536
New +$414K ﹤0.01% 4538

Other funds holding GOSS

6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co's GOSS Position: Q2 2026 in Review

D.E. Shaw & Co increased its Gossamer Bio (GOSS) stake by 10,417% in Q2 2026, buying an estimated $11.3M and bringing the position to 511,991 shares worth $6.74M. The position accounts for ﹤0.01% of the portfolio, ranked #2169.

D.E. Shaw & Co first reported a position in GOSS in Q1 2022 and has held it in 14 quarters since. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • D.E. Shaw & Co held 511,991 shares of Gossamer Bio worth $6.74M as of Q2 2026.
  • D.E. Shaw & Co bought 507,123 Gossamer Bio shares in Q2 2026, an estimated $11.3M.
  • Gossamer Bio made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #2169 holding.
  • D.E. Shaw & Co first reported a position in Gossamer Bio in Q1 2022 and has held it in 14 quarters since.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.